학술논문
A Phase II Study Evaluating the Interest to Combine UCPVax, a Telomerase CD4 TH 1-Inducer Cancer Vaccine, and Atezolizumab for the Treatment of HPV Positive Cancers: VolATIL Study
Document Type
Article
Author
Source
In: Frontiers in Oncology . (Frontiers in Oncology, 19 July 2022, 12)
Subject
Language
English
ISSN
2234943X